ARCHIVES

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996

In Brief: Einstein Moves To Florida; Crystal, Nienhuls To Leave NIH; Collins Heads Genome Project

February 19, 1993

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

JR Adams Elected President, Ovarian Cancer Coalition.

March 9, 2001